Use Of An Entirely Human Milk-based Diet In Very Low Birth Weight
Transcription
Use Of An Entirely Human Milk-based Diet In Very Low Birth Weight
Use Of An Entirely Human Milk-based Diet In Very Low Birth Weight Infants: Review Of Current Evidence And Future Directions Steven A. Abrams, MD Professor of Pediatrics Baylor College of Medicine sabrams@bcm.edu Disclosure I have disclosed the following relevant financial relationships: Mead Johnson, Inc. – Grant Holder Outline Human milk (HM): safe and effective enteral nutrition in very low birth weight (VLBW) neonates Early research related to human milk and sepsis/NEC Role of human milk-based fortifier in allowing for adequate growth in VLBW neonates Current controlled trials of necrotizing enterocolitis (NEC) and other outcomes using an all human milk-based diet Recent combined analysis of human milk trials Future directions including research into other populations Conclusions Human Milk Use And Outcomes Of ELBW Infants At 30 Months Of Age At 30 months, human milk was associated with increased Bayley MDI scores, BRS, and fewer re-hospitalizations For every 10 mL/kg of HM in the NICU, at 30 months: MDI increased by 0.59 points, PDI by 0.56 points Re-hospitalization decreased by 5% Vohr B R, et al., 2007 Human Milk And Intellectual Performance In Premature Infants At 8Y Significant factors affecting IQ: Social Class - 3.5/class Mechanical Ventilation - 2.6/week Mother’s Education + 2.0/group Female Gender + 4.2 Receipt of Human Milk + 8.3 IQ points IQ: Weschler Scale, WISC-R Lucas, Lancet 1992;339:261 Donor Human Milk And NEC: Early Data Several meta-analyses support decreased risk of NEC with donor HM. Studies are older, mixed population, not always fortified. Morales and Schanler: Semin Perinatol 31:83-88 © 2007 ‘Survival’ Curves For NEC Or Death* By Amount Of Human Milk (Ml/Kg/D) 1.00 100 ml 0.95 Survival Estimate 50 ml 0.90 20 ml 10 ml 0.85 0 ml *For NEC or Death after 14 days, adjusted for birth weight, race, PDA treatment, ventilation, and site Meinzen-Derr, et al NICHD Neonatal NetworkJ Perinatol 2009 0.80 0 10 20 30 40 50 60 70 Postnatal age (d) 80 90 100 110 120 Nutrients Limited In Human Milk For Very Preterm Infants Protein: Need extra to continue to resolve deficit and to support catch-up growth. Key component in length growth. Minerals: Calcium, phosphorus, iron and zinc Vitamins: Especially vitamin D Unless mother is receiving mega-dose (6400 IU/d) vitamin D supplementation, there is negligible vitamin D in human milk. Energy Density: Primarily limited by feeding volume, also caloric density Protein Requirements From Enteral Nutrition In Very Preterm Infants Factorial approach Growth – 2.0 g/d Losses – 0.9 g/d Unabsorbed – 0.5 g/d Total: 3.4 g/d For 800 g infant – about 4 g/kg/d European (ESPGHAN) Recommendations Agostoni et al. JPGN, 2010; 50:85-91 AAP Policy Statement 2012 “Breastfeeding And The Use Of Human Milk” “All preterm infants should receive human milk” Human milk should be fortified, with protein, minerals, and vitamins to ensure optimal nutrient intake for infants weighing <1500 grams at birth Pasteurized donor human milk (DHM), appropriately fortified, should be used if mother’s own milk is unavailable or its use is contraindicated American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 129(3): e827-e841; 2012. Growth And Donor Human Milk Small descriptive studies suggest that the nutrient content of DHM is lower in fat, calories, protein, sodium, and calcium as compared to formula Premature infants have increased nutritional requirements All infants with a birth weight ≤1250 g are at risk for poor growth and metabolic abnormalities One meta-analysis showed that DHM is associated with slower growth in the early postnatal period Boyd et al: Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 92: F169-F175; 2007. Growth Parameters Targeted growth for preterm infants is based upon estimated intrauterine growth from historical cohort studies1,2 Weight 15.0 g/kg/day Length 1.0 cm/week Head circumference 0.7 cm/week 1. Lucas A ,et al: Multicentre trial on feeding low birth weight infants: effects of diet on early growth. Arch Dis Childhood. 59: 722-730; 1984. 2. Lubchenco LO, et al: Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics. 37(3): 403-408; 1966. Postnatal Growth Failure NICHD Neonatal Research Network (1995-1996) 4438 infants 501-1500 g BW 22% weight <10th percentile at birth 97% had growth failure at 36 weeks corrected age Infants weighing 501-1000 g BW 17% weight <10th percentile at birth 99% had growth failure at 36 weeks corrected age Lemons JA, Bauer CR, Oh W, et al: Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics. 107 (1): e1; 2001. Why Is This Important? 495 Infants 501-1000 g birth weight (BW) were divided into quartiles of in-hospital growth velocity rates and evaluated at 18-22 months corrected gestational age As the rate of weight gain increased from 12.0 to 21.2 g/kg/day (quartile 1 to 4), head circumference increased from 0.77 to 1.07 cm/wk Incidence decreased significantly for: Cerebral palsy, Low Bayley II Mental Development Index Psychomotor Development Index, neurodevelopmental impairment, re-hospitalization Ehrenkranz RA, et al: Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 117(4): 1253-1261; 2006. Approaches To Human Milk Fortification To Meet Nutrient And Growth Requirements Commercial cow milk protein based fortifiers (liquid or powder) Addition of powdered preterm/transitional formula Widely used, exposes infant to non HM protein. We use this for larger preterms Risk of contamination of non-sterilized powder. We rarely recommend this especially before 44 weeks postmenstrual age (PMA). Several daily feeds of formula, others non-fortified HM Limited added nutrients, best at discharge phase Additional Approaches Supplementation with non-cow milk based products Supplementation with fat, protein, carbohydrates individually Currently available, relatively little data Also may be non-sterile, difficult to use and does not provide minerals. We do not currently recommend this. Human milk protein-based fortifier No exposure to either non-sterile products or cow milk protein. Our current approach for infants <1250 g BW and some 1250-1500 g BW Concern about growth of infants receiving only donor milk An All HM Diet: Methods Of Our Evaluation Single center, prospective observational cohort study of preterm infants weighing ≤1250 g BW fed an all human milk protein-based diet Inclusion criteria Infants admitted within first 48 hours of birth Full enteral feedings achieved within 4 weeks Exclusion criteria Infants with major congenital anomalies Death Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Our Evaluation: Hypothesis We hypothesized that a feeding protocol providing an exclusive human milk-based diet would meet growth standards in infants ≤1250 g BW and lead to decreased extrauterine growth restriction Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Feeding Guidelines ≤ 1250g BW Day of Feed Human Milk [EBM or Donor] kcal/oz Feeding Volume (mL/kg/d) TPN (mL/kg/d) Lipids (mL/kg/d) Total Fluids = Enteral + TPN + IL (mL/kg/d) 1 20 15-20 90-100 5-10 120 2 20 15-20 95-105 10-15 130 3 20 15-20 115-120 15 150 4 20 40 95 15 150 5 24 (add donor milk-derived fortifier +4) 60 75 15 150 EBM = expressed breast milk; IL = intravenous lipid; TPN = total parenteral nutrition. www.neonate.net Baylor College of Medicine, Section of Neonatology, Department of Pediatrics. Guidelines for Acute Care of the Neonate. 21st Ed. 2013-2014. Feeding Guidelines ≤1250 g BW Day of Feed 6 7 8 9 10 11 Human Milk [EBM or Donor] kcal/oz 24 (donor milk-derived fortifier +4) 24 (donor milk-derived fortifier +4) 26 (add donor milkderived fortifier +6) 26 (donor milk-derived fortifier +6) 26 (donor milk-derived fortifier +6) 26 (donor milk-derived fortifier +6) Feeding TPN Lipids Total Fluids = Volume (mL/kg/d) (mL/kg/d) Enteral + TPN + (mL/kg/d) IL (mL/kg/d) 80 55-70 15 or Off Lipids 150 100 50 0 150 100 50 0 150 120 Off TPN 0 120 Off TPN or IV fluids 140 0 0 140 150 0 0 150 Full enteral feeds Baylor College of Medicine, Section of Neonatology, Department of Pediatrics. Guidelines for Acute Care of the Neonate. 21st Ed. 2013-2014. Table 1: Patient Demographics n=104 Birth weight (g) Gestational age (wk) Male, n (%) Race, n (%) White Black Hispanic Other Birth length (cm) Birth HC (cm) APGAR 5 minute Inborn, n (%) Antenatal Steroids, n (%) 913 ± 182* 27.6 ± 2.0* 49 (47) 28 (27) 40 (38) 24 (23) 12 (12) 34.4 ± 2.6* 24.2 ± 1.8* 7 ± 2* 59 (57) 77 (74) ± SD Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. *Mean Growth Velocities From Birth To Discharge *Mean ± SD * Hair AB, et al: Human milk feeding supports adequate growth in infants ≤1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Growth Outcomes n=104 Weight gain (g/kg/d) Length (cm/wk) Head circumference (cm/wk) Days to regain birth weight Days to full feeds Days to fortification of feeds Volume feeds were fortified (mL/kg/d) Parenteral nutrition days Transition to bovine products (wk) SGA at birth, n (%) SGA at discharge or 40 weeks PMA, n (%) 24.8 ± 5.4* 0.99 ± 0.23* 0.72 ± 0.14* 8.4 ± 4.0* 14 (12,19)† 10 (8,14)† 80 (60,90)† 13 (10,19)† 36 ± 1.5* 22 (21) 45 (43) *Mean ± SD, †Median (25th, 75th percentile) Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Secondary Outcomes n=104 Medical NEC 3 (2.8)* Surgical NEC 1 (1.0)* Spontaneous intestinal perforation 2 (1.9)* Late onset sepsis 14 (13)* Patent ductus arteriosus 49 (47)* No IVH 78 (75)* Intraventricular hemorrhage: Grade III or IV Bronchopulmonary dysplasia Weight at discharge (g) Length of stay (d) 5 (5)* 46 (44)* 2795 (2247,3155)† 82 (68,106)† *n (%), †Median (25th, 75th percentile) Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Postnatal Growth Failure 43% of all infants had a weight <10th percentile at discharge or 40 weeks PMA 21% of infants were small for gestational age (SGA) at birth 100% of these infants had a weight <10th percentile at discharge or 40 weeks PMA 79% of infants were born appropriate for gestational age 22% of this group had postnatal growth failure Implications: We can improve outcomes in AGA infants but more work needs to be done for appropriate for gestational age (SGA) ones Hair AB, et al: Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Research Notes. 6: 459; 2013. Controlled Trials Of Outcomes Of An All Human Milk Diet Study Design Sullivan et al., J Pediatr 2010 Effect Of Donor Human Milk Fortifier (HMF) On NEC Decrease in NEC with donor derived HMF of 50%, surgical NEC 80%. Number needed to treat: 8-10 Sullivan et al., J Pediatr 2010 Results N = 24 Bov (formula) and 29 Hum (all HM protein) Cristofalo et al. J Pediatr 2013:163;1592-5. Group Characteristics Abrams et al, Breastfeed Med 2014;9:281-5. Overall Outcomes Abrams et al, Breastfeed Med 2014;9:281-5. Outcome Models Abrams et al, Breastfeed Med 2014;9:281-5. Study Conclusions Provision of an exclusively human milk diet during the early postnatal period, a diet devoid of cow milk protein, is associated with lower risks of death, NEC, NEC requiring surgery, and sepsis in extremely premature infants The cost of major complications of extreme prematurity, such as sepsis and NEC, is very high. Lifetime costs are likely much higher because of the increased risk of long-term neurodevelopmental problems in infants who have had NEC requiring surgery Cost/Benefit Of NEC vs. Exclusively Human Milk-Based Diet In Extremely Low Birth Weight (ELBW) Cost/Length of Stay over and above cost of ELBW with no NEC Medical NEC Surgical NEC LOS (days) +11.7 days +43.1 days Cost (2011 US$) +$74,004 +$198,000 Infants fed with 100% human milk-based products had: • Total expected costs of hospitalization resulting is savings of: • 3.9 NICU days • $8,167 per each ELBW Vaidyanathan, et al., 2011 A Research Agenda For An All Human Milk Based Diet For High Risk And Preterm Infants Comparison with non-cow milk based fortification Evaluation of larger infants Effects on congenital bowel and congenital heart disease Long term neurocognitive benefits Effects on breast-feeding success in hospital and after discharge Conclusions Human milk is the optimal primary food for preterm infants Benefits to decreased rates of NEC are substantial Optimal methods of fortification when needed remain uncertain Available data suggest that fortification with an all human milk diet leads to excellent growth and low rates of NEC Expansion of this approach to other populations needs further investigation Thanks for making it to the end! sabrams@bcm.edu Q & A With Dr. Abrams What is your experience with using the Human Milk Cream product to fortify feeds for ELBW infants? When might you use this product, in addition to 26 cal/oz fortified human milk? Q & A With Dr. Abrams Do you start breast milk right away in the VLBW (i.e. day 1)? If so, and the mom is unable to pump enough milk, would you start banked milk day 1, start with a formula and transition, or keep on hyperal only waiting for the pumped milk to come in? Q & A With Dr. Abrams Have Human Milk-based Fortifiers been approved for use anywhere outside of the United States? Q & A With Dr. Abrams Can you please speak to the apparent increase in the rate of ROP in the 2nd study? (Cristofalo?) Q & A With Dr. Abrams Can you please comment on the fact that the bovine group in the studies included formula in their diet in addition to cow milk fortifier? Was a sub-group analysis done comparing all HM diet (including HM fortifier) with all HM diet with cows-milk fortifier? Are there plans to study an all human milk group with HM foritifier vs all human milk with cow's milk fortifier? Q & A With Dr. Abrams It seems like the AAP has placed NICUs on notice that the use of cow milk formula in VLBW is not standard of care. Why do you think we are slow to adopt this change? Or have you seen a marked increase in the use of banked breast milk? Q & A With Dr. Abrams What are the most successful techniques you have used to persuade mothers who had no plan to breastfeed to provide some or any of their milk? What is the cost of human milk based fortifiers compared to cow's milk fortifiers? What countries have more milk banks and greater human milk available? Q & A With Dr. Abrams Do you have any suggestions on how to encourage mothers to donate breastmilk to milk banks? Have any studies identified the most common reasons mothers choose not to provide breastmilk? Q & A With Dr. Abrams I have heard of mothers, mostly from foreign countries, sharing their breastmilk with others; what are the dangers associated with this? Are there any studies on this? Do you know what countries have the highest and lowest rates of breastfeeding? Q & A With Dr. Abrams Do you feel that there might be less need for human milk based human milk fortifiers now that we have second generation HMF (extensively hydrolyzed protein with higher protein)? Is anyone studying 100% human milk with bovine fortifiers compared to 100% HM with HM based fortifiers? Are we concerned with supply of human milk based human milk fortifiers if this becomes the gold standard? Are we concerned with Prolacta recruiting moms who would otherwise donate to HMBANA approved milk banks? Q & A With Dr. Abrams What is your hospital's protocol for introducing bovine based fortifiers after an infant has been receiving an all human milk based diet? Do you begin to use bovine based fortifiers at a certain age/weight? Q & A With Dr. Abrams Are you familiar with the practice of starting half strength feeds or can offer evidence to oppose it? Q & A With Dr. Abrams How do you get around the cost of Prolacta when there is no third cost reimbursement? Q & A With Dr. Abrams In your slide on supplementation of HM options, you mention that supplementation with non-cow milk based products is an option. Which products are you referring to? Q & A With Dr. Abrams Do you get informed consent for using banked milk in your preterm population? If so what if the mother says no? Given the risk of NEC, etc. how forceful are you with that decision in a VLBW infant? Q & A With Dr. Abrams Do you have challenges with hospitals not willing to place a human milk fortifier on formulary due to cost?